NYSE: CVRS PRICE: 1.03 -0.04 -3.74% Volume: 612,372 20 minute delay. February 23, 2018

Leadership Team

Mark J. Toland , , , President and CEO

Mark J. Toland has been in the medical device space for over 20 years. Prior to joining Corindus as President & CEO, he served as Senior Vice President of Boston Scientific leading BSC's growth and market-innovation initiatives; directly managing corporate sales, marketing, commercial operations, and global solutions. Previously, he led BSC's Interventional Cardiology, Cardiac Rhythm Management, Peripheral Interventions, and Electrophysiology divisions, overseeing over 2000 employees in sales, commercial operations, and customer service. He was accountable for over $4B in revenue and helped lead the integration efforts of key acquisitions, such as Guidant Corporation, Cameron Health (S-ICD), Bridgepoint Medical (CTO), and Watchman (LAAC) that has helped propel the company back to growth. Mark serves on numerous industry boards and has been a faculty member/speaker at numerous medical conferences. He holds a bachelor's degree from the University of Louisville.

J. Aaron Grantham, MD , , , Chief Medical Officer

J. Aaron Grantham, MD is a practicing Interventional Cardiologist with Saint Luke's Mid America Heart Institute, a member of Saint Luke's Health System. Dr. Grantham is an Associate Professor at the University of Missouri-Kansas City School of Medicine, Director of the school's Cardiovascular Disease Fellowship Program, and Director of Cardiovascular Medical Education at Saint Luke's Hospital. He brings his experience as an innovator in the treatment of chronic total occlusions (CTOs) to his role as CMO for Corindus where he is leading efforts to develop clinical data to advance the CorPath System's applicability for additional clinical indications. Dr. Grantham earned his Doctor of Medicine at the University of Kansas in 1991 and continued at University of Kansas for his Internal Medicine Residency. Following residency, he completed fellowship training in Cardiovascular Disease and Interventional Cardiology at the Mayo Graduate School of Medicine, Rochester, Minnesota.

Jeff Lemaster , , , Chief Commercial Officer

Jeff Lemaster leads the commercial strategy and development for Corindus Vascular Robotics. Jeff has over 20 years of commercial sales and marketing experience in the cardiovascular medical device industry, along with extensive interventional cardiology and peripheral vascular global product launch experience. Most recently, Jeff served as Global Vice President of Marketing at C.R. Bard, Inc., where he was responsible for all commercial marketing activities for the company’s $1.1B global peripheral vascular division. Jeff has a proven track record of commercial success holding senior sales and marketing leadership positions at top medical device companies ACIST Medical Systems and Boston Scientific Corporation. Jeff is a proud graduate of the University of Michigan.

Tal Wenderow , , , Co-Founder, Executive Vice President International & Business Development

Tal Wenderow co-founded Corindus in 2002 with Professor Rafael Beyar in Israel and served as the Chief Executive Officer at inception. Tal started with Professor Beyar's idea and single-handedly formed Corindus. He was responsible for managing all research and development, regulatory, Intellectual property, business development and marketing of the Company until the Series B round of financing. Beginning in 2010, Tal served as the Executive Vice President of Marketing & Business Development and is now leading the International Division of Corindus. Tal holds a Bachelor of Science, summa cum laude, in Mechanical Engineering from Technion in Israel and has completed Executive Program for Life Sciences at the Merage Foundation, Merage Business School, University of California, Irvine, CA.

David Long , , , Senior Vice President and Chief Financial Officer

David Long is an experienced finance leader with over 20 years of global experience. David joined Corindus in September 2011 after more than 7 years at Thermo Fisher Scientific where he served as the Vice President of Finance for their Laboratory Equipment Division and Vice President of Finance for the combined Laboratory Equipment and Laboratory Workstations businesses. Prior to then, David held a variety of financial management roles at PPG Industries, Polaroid Corporation, and International Rectifier. David has also served as an Adjunct Professor in the Department of Accountancy at Bentley University. He holds a Master of Public Administration from the University of Pennsylvania and a Bachelor of Science in Finance from the University of Massachusetts.

Suzette Jaskie , , , Senior Vice President, Clinical, Regulatory & Medical Affairs

Suzette Jaskie oversees the company’s medical education programs and is responsible for managing the Corindus Vascular Robotics’ physician advisory board and steering committee. In this role, Suzette is also responsible for developing and managing the company’s Center of Excellence programs, which provides premier vascular robotic education to physicians and staff across the nation. Suzette brings over 20 years of healthcare experience to Corindus Vascular Robotics, with much of her experience focused in the field of cardiology. Most recently, Suzette served as President and Chief Executive Officer at MedAxiom Consulting. Prior to MedAxion, Suzette served as Executive Director of the Frederik Meijer Heart & Vascular Institute, Grand Rapids, MI, where she worked with co-medical directors to conceive, build and manage the multidisciplinary entity responsible for managing the regional cardiovascular service line of Spectrum Health. Suzette holds a Master of Business Administration from the University of Hartford and a Bachelor of Science in English and Communications from the University of Wisconsin-Madison.

Doug Teany , , , Senior Vice President of R&D and Operations

Doug Teany has an 18-year track record of driving operational excellence in the medical device and pharmaceutical industries. Doug joined Corindus from East River Consulting Group where he specialized in scaling operations for emerging medical device companies. Previously, Doug served as Vice President in Boston Scientific's Research & Development organization, responsible for strategy and operations of its global clinical and preclinical research functions. During his tenure at Boston Scientific, Doug played a key role in returning the company to profitability, contributing significantly to operating income growth through product development optimization and operational performance improvement. He designed and led numerous organizational transformations, improved operations for multiple large-scale laboratory and research facilities, and optimized the performance of pivotal development programs such as the Promus Element™ Stent and Lotus™ Valve TAVI Systems. Prior to his work at Boston Scientific, Doug worked as a management consultant for Praxis Life Sciences and held leadership roles in Abbott Laboratories' Regulatory and Information Technology organizations. Doug holds Master of Science and bachelor’s degree from Purdue University and served as an Engineer in the United States Army Reserves.

Nora Dutta , , , Vice President of Human Resources

Nora Dutta brings 19 years of human resources experience including organizational development, strategy, recruiting, and employee relations, joining Corindus from AMAG Pharmaceuticals where she served as Senior Director of Human Resources. In that role, Nora provided strategic leadership on a transformational acquisition, was a member of the senior management team for its Hematology and Oncology Division and lead AMAG's Human Resources Operations and Recruitment functions. Previously, Nora served as a Strategic Human Resources Business Partner to the Global Strategy, Marketing and Business Services functions at Boston Scientific. She was also a key team member on numerous acquisitions and strategic business initiatives over her 8-year tenure with Boston Scientific.

Email Alerts

Mailing Lists *

Email Address *

Enter the code shown above.

Investor Contact

Scott Madden
508-653-3335 Ext 504